Keyphrases
Cost-effectiveness
100%
Herpes Simplex Virus 2 (HSV-2)
100%
Antenatal Screening
100%
Counseling
50%
Herpes Simplex Virus
50%
Antepartum
50%
Antibody Screening
50%
Virus Detection
50%
Neonate
25%
Pregnant Women
25%
Quality of Life
25%
Treatment Strategy
25%
Standard of Care
25%
Current Guidelines
25%
Sensitivity Analysis
25%
Herpesvirus Infection
25%
Neurological Sequelae
25%
Herpes Simplex Virus Type 1 (HSV-1)
25%
Design Decisions
25%
Male Partner
25%
Genital Herpes Simplex Virus
25%
Neurologic Death
25%
Decision Analysis
25%
Week of Gestation
25%
Herpes
25%
Life-years Gained
25%
Screening in Pregnancy
25%
Acyclovir Prophylaxis
25%
Genital Herpes
25%
Neonatal Herpes
25%
Medicine and Dentistry
Human Alphaherpesvirus 1
100%
Antenatal Screening
100%
Cost-Effectiveness Analysis
100%
Health Care Cost
60%
Counseling
40%
Herpes Simplex Virus
40%
Herpes Genitalis
40%
Antibody Screening
40%
Neonates
20%
Pregnancy
20%
Sequela
20%
Herpes Simplex Virus 2
20%
Herpes Simplex
20%
Screening in Pregnancy
20%
Aciclovir
20%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Herpes Simplex
100%
Genital Herpes
28%
Counseling
28%
Antibody Screening
28%
Health Care Quality
14%
Quality of Life
14%
Practice Guideline
14%
Neonates
14%
Aciclovir
14%